This inventor holds 1 USPTO granted patent. Top assignee: Cornell University. Active years: 2002.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2002
Title: The Innovative Contributions of Daniel R Nussenzveig
Introduction
Daniel R Nussenzveig is a prominent inventor based in New York, NY. He has made significant contributions to the field of biochemistry, particularly in the area of G protein-coupled receptors (GPCRs). His innovative approach to discovering peptide agonists and negative antagonists has the potential to advance therapeutic strategies in various medical applications.
Latest Patents
Nussenzveig holds a patent titled "Methods of identifying peptide agonists or negative antagonists of a G protein coupled receptor." This invention outlines a strategy to discover small peptides that can activate or inactivate GPCRs. The method involves using combinatorial peptide libraries to screen millions of random peptides for their activity as agonists or negative antagonists. By expressing a peptide from the library tethered to a GPCR in a cell, researchers can monitor the cell's response to determine the peptide's effectiveness. This innovative approach has the potential to enhance drug discovery processes.
Career Highlights
Nussenzveig's career is marked by his dedication to research and innovation in the field of biochemistry. He has been instrumental in developing methods that facilitate the identification of peptide interactions with GPCRs. His work has contributed to a deeper understanding of receptor biology and its implications for drug development.
Collaborations
Throughout his career, Nussenzveig has collaborated with esteemed colleagues, including Marvin C Gershengorn and Elizabeth Geras-Raaka. These collaborations have fostered a rich exchange of ideas and have furthered advancements in their shared research interests.
Conclusion
Daniel R Nussenzveig's contributions to the field of biochemistry, particularly through his innovative patent on GPCRs, highlight his role as a leading inventor. His work not only enhances our understanding of receptor interactions but also paves the way for future therapeutic developments.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
